Production (Stage)
Encompass Health Corporation
EHC
$118.90
$0.290.24%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.59% | 4.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.59% | 4.00% | |||
| Cost of Revenue | 0.66% | 3.33% | |||
| Gross Profit | 7.68% | 4.94% | |||
| SG&A Expenses | -2.89% | 1.17% | |||
| Depreciation & Amortization | 1.54% | -0.51% | |||
| Other Operating Expenses | 5.38% | 1.98% | |||
| Total Operating Expenses | 1.34% | 2.70% | |||
| Operating Income | 14.94% | 11.10% | |||
| Income Before Tax | 18.47% | 9.58% | |||
| Income Tax Expenses | 10.64% | 4.44% | |||
| Earnings from Continuing Operations | 20.27% | 10.83% | |||
| Earnings from Discontinued Operations | -225.00% | 157.14% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -3.93% | -11.31% | |||
| Net Income | 25.31% | 11.74% | |||
| EBIT | 14.94% | 11.10% | |||
| EBITDA | 11.57% | 7.93% | |||
| EPS Basic | 25.19% | 11.61% | |||
| Normalized Basic EPS | 25.28% | 8.39% | |||
| EPS Diluted | 25.55% | 11.52% | |||
| Normalized Diluted EPS | 26.15% | 8.28% | |||
| Average Basic Shares Outstanding | 0.50% | 0.10% | |||
| Average Diluted Shares Outstanding | -0.20% | 0.20% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.16% | 0.01% | |||